Previous Close | 0.5100 |
Open | 0.5250 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.5250 - 0.5250 |
52 Week Range | 0.1590 - 0.7150 |
Volume | 3,000 |
Avg. Volume | 79 |
Market Cap | 18.384M |
Beta (5Y Monthly) | 1.25 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0870 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Toronto, Ontario--(Newsfile Corp. - December 31, 2020) - Canntab Therapeutics Limited. (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) ("Canntab" or the "Company"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the closing of a non-brokered private placement (the "Offering") of secured convertible debentures of the Company ("Convertible Debentures"), pursuant to which the Company issued Convertible Debentures for gross proceeds of $1,575,000 (the "Convertible Debentures"). The ...
TORONTO, Dec. 3, 2020 /CNW/ - The Canadian Securities Administrators (CSA) today published a consultation paper to facilitate discussion about activist short selling.
QUÉBEC CITY, Nov. 28, 2020 /CNW Telbec/ - The most recent data on the evolution of COVID-19 in Québec show 1,480 new cases, bringing the total number of people infected to 139,643.